Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT01646645 · COMPLETED
Trial details
- NCT number
- NCT01646645
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-13
- Primary completion
- 2019-12-11
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.